BlackRock Global Funds ‐ World Healthscience Fund (AUD‐Hedged) A2

The World Healthscience Fund seeks to maximise total return. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed.

BlackRock Global Funds ‐ World Healthscience Fund (AUD‐Hedged) A2

The World Healthscience Fund seeks to maximise total return. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed.

15.92%

3 Years Annualised

0.72

Sharpe Ratio

USD $11,669.83

Fund Size (Mil)

Fund Type

UCITS

Geographies

Global

Industry Focus

Health Care

Fund Style

Growth

Distribution

Non-distributing

Inception Date

06/04/2001

Track Records

As part of Venture Smart’s rigorous selection and due diligence process, we analyse the fund’s investment record for the specific fund strategy in great detail. We scrutinize investment level performance, comparing investment strategy with results and understanding the team’s actions to drive overperformance and manage under performance.

Terms & Legal

Investment Manager

BlackRock Asset Management North Asia Limited

Fund Manager

Erin Xie, Jeff Lee, Xiang Liu

Management fee

1.50%

Performance fee

0.00%

Max Initial Charge

5.0%

Redemption Fee

Not Applicable

Remarks

• You generally buy and redeem shares at the Fund’s next-determined price as long as the Hong Kong Representative or the Transfer Agent receives your request in good order before the 6:00p.m. cut-off (HK time). Please check whether your distributor has an internal cut-off time which is earlier than this.
• The net asset value of the Fund is calculated daily. Prices of shares are published each business day on www.blackrock.com/hk. This website has not been reviewed by the SFC.
• The updated list of currently available shares is available from the Hong Kong Representative.

Important Information

• The Fund’s investments in equities could incur significant losses due to higher fluctuation of equity values. The Fund’s investments are concentrated in the healthcare, pharmaceuticals and other healthscience sectors. This may result in greater volatility than more broad-based investments.
• The Fund is subject to currency risk, emerging market risk, foreign investments restrictions risk, small-cap companies’ volatility and liquidity risks and currency conversion risk including Renminbi denominated Classes.
• The Fund may use derivatives for hedging and for investment purposes. However, usage for investment purposes will not be extensive. The Fund may suffer losses from its derivatives usage.
• The value of the Fund can be volatile and can go down substantially within a short period of time. It is possible that a certain amount of your investment could be lost.
• Investors should not make investment decisions based on this document alone. Investors should refer to the Prospectus and Key Facts Statement for details including risk factors.

Leave your details to learn more

  •  
Disclaimer

Warning statement

Past performance is not a guide to future performance. Returns may increase or decrease as a result of currency fluctuations. All performance data is calculated NAV to NAV, net of fees, dividends reinvested and does not take account of commissions and costs incurred on the issue and redemption of units. US/Hong Kong dollar-based investors are exposed to currency fluctuations where funds are denominated in currencies other than US/Hong Kong dollars.

Performance data is not available if a share class is less than 12 calendar months old. However performance data for other share classes of the same fund will be available in the factsheet, provided such share classes are more than 12 calendar months old. Performance between share classes may differ due to factors such as hedging strategies and fees.

Important Information

  • The investment may involve risks that could result in loss of part or entire amount of investors’ investment.
  • Investors should not solely rely on this document to make any investment decision. You should read and understand the offering documents for further fund details including risk factors.
logo_only
VSFG is committed to helping individuals, families and corporations meet their financial objectives.

Contact

Headquarters and principal place of business

23/F, Lee Garden Five, 18 Hysan Avenue, Causeway Bay, Hong Kong

Causeway Bay Office

12/F, Phase II, China Taiping Tower, 8 Sunning Road, Causeway Bay, Hong Kong